Navigation Links
Genetic Test Predicts Response to Warfarin
Date:3/5/2008

Using it could save money and lives, expert says

WEDNESDAY, March 5 (HealthDay News) -- Variations of a gene that determines a person's sensitivity to warfarin are important in determining the initial doses of the anti-clotting drug, researchers report.

That information already is being put to medical use. Last August, the U.S. Food and Drug Administration changed the labeling to say that doctors should consider a genetic test when first prescribing warfarin, better known by its brand name, Coumadin.

"This test can save $1.1 billion in health-care costs and 18,000 lives a year," said Dr. Raymond Woosley, president of the Critical Path Institute, a private organization that is working with the FDA and the biotechnology industry on the subject.

The FDA estimates that 2 million Americans take warfarin to prevent potentially dangerous blood clots. Reasons range from implantation of an artificial heart valve to the abnormal heartbeat called atrial fibrillation.

But warfarin is a notoriously difficult drug to manage, especially at the start. Too much can lead to hemorrhages; too little can allow clots to form. One individual may do well on 1.5 milligrams a day, while another may require 20 milligrams daily.

Some medical centers run elaborate tests to determine the starting dose, but "the standard way is to start with 5 milligrams, then titrate the doses according to blood tests that show the response to warfarin," said Dr. C. Michael Stein, a professor of medicine and pharmacology at Vanderbilt University. He was the leader of the group reporting the finding in the March 6 issue of the New England Journal of Medicine.

Two genes are known to affect the response to warfarin. One, designated CYP2C9, governs the metabolism of the medication, or how fast it is eliminated from the body. The other, designated VKORC1, governs sensitivity, or how the body reacts to a given dose of warfarin. Th
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Many Parents Share Genetic Test Findings With Kids
2. Genetic predisposition increases childhood asthma risk
3. New Alzheimers findings: High stress and genetic risk factor lead to increased memory decline
4. Test Spots Genetic Damage Done by Smoking
5. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
6. Scientists highlight benefits of genetic research in sport, but warn of ethical concerns
7. Genetics Hold Promise, Challenges for Cancer Care
8. Researchers genetically engineer micro-organisms into tiny factories
9. Study Questions Genetic Screening for Treatable Diseases
10. Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits
11. Genetic variation affects smoking cessation treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Test Predicts Response to Warfarin
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Lecrae is ... been noted everywhere from Rolling Stone and The New York Times to Billboard Magazine ... life experiences are one of the many reasons why so many people are taking ...
(Date:6/30/2015)... New York, NY (PRWEB) , ... June 30, ... ... and students are critical in order to enhance successful student outcomes. According ... on the teacher’s capacity to adapt.” Teachers must be able to show “all ...
(Date:6/30/2015)... ... June 30, 2015 , ... Americans report feeling more stressed than ever ... mornings, which puts stressed out people right over the edge. , Almost half ... sleep deprivation every night. Sleeping pills now lead the list of the most prescribed ...
(Date:6/30/2015)... ... June 30, 2015 , ... Curly Hair Solutions™ is honoured to attend Cosmoprof ... the US, featuring products from all over the world. For the first time ever, ... line of hair styling products focused entirely on meeting the needs of all ...
(Date:6/29/2015)... (PRWEB) , ... June 30, 2015 , ... Sublime Beauty ... 50% Off offer. The oil, ideal for natural skincare and even culinary uses, ... easy way is something most people desire, and Oil Pulling can accomplish this. Oil ...
Breaking Medicine News(10 mins):Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 3Health News:Lessons On Leadership - Top 12 Global Teacher Bloggers Reveal the Best Strategies for Building Positive Leadership in Global Classrooms 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 3Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2
... Oct. 28 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Co., Inc., (Amex: ... traditional Chinese medicine ("TCM") based in Chengdu, China,today ... approved a $3,million stock repurchase program., On ... the Company to,repurchase up to $3.0 million of ...
... BPUR ) announced today that it has ... until March 16, 2009, to regain compliance,with Marketplace ... $1.00,for continued listing. The deadline would have been ... minimum bid price requirement because,of turmoil in the ...
... Dissatisfaction with Pain,Management, SAN FRANCISCO, Oct. 28 ... from large-scale rheumatoid arthritis (RA) surveys,collectively called the ... substantially less knowledge of RA therapies than their,physicians ... between,physicians and nurses over who should be charged ...
... Comply by November 1st, BRENTWOOD, Tenn., Oct. 28 ... will delay penalties until May 1, 2009 for,organizations not ... welcomed relief for those defined as "Creditors" who have ... deadline., Organizations affected by the FTC,s delay in ...
... this year,s liver meeting in San ... Oct. 28 The goal of researchers from the,Mayo Clinic ... determine the,effects of fatty liver disease in children up to ... nonalcoholic fatty liver disease,(NAFLD) is the most prevalent liver disease ...
... & Sullivan is,pleased to announce that the firm will ... Innovation Awards. The Awards will be announced,during a banquet ... San Antonio,Texas., The Healthcare Innovation Awards are given ... delivery and management of healthcare.,Such companies have shown success ...
Cached Medicine News:Health News:Tianyin Pharmaceutical Co., Inc. Authorizes $3.0 Million Stock Repurchase Program 2Health News:Tianyin Pharmaceutical Co., Inc. Authorizes $3.0 Million Stock Repurchase Program 3Health News:Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance 2Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 2Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 3Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 4Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 5Health News:FTC Extends Final Red Flag Compliance Deadline for Creditors 2Health News:Severe Health Risks Follow Adults Who Were Diagnosed With Nonalcoholic Fatty Liver Disease as Children 2Health News:Frost & Sullivan to Present the 2008 Excellence in Healthcare Innovation Awards 2Health News:Frost & Sullivan to Present the 2008 Excellence in Healthcare Innovation Awards 3
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ – Small Cap IR ... agreement to supply custom Arrayit blood card technology to ... vault on earth. Vivos offers an impervious, impenetrable and ... man, woman and child on Earth, a safe and ... Arrayit blood cards allow the rapid collection, separation, drying ...
(Date:6/30/2015)... 30, 2015  Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and ... results from a Category 3 human abuse ... extended-release, oral oxycodone product candidate in late-stage ... severe enough to require daily, around-the-clock opioid ...
(Date:6/30/2015)... England , June 30, 2015 ... acted as advisor to Chip-Man Technologies Oy (CMT) on ... (Yokogawa). The assets relate to CMTs world leading capabilities ... is the latest in a series of successful global ... PharmaVentures clients. Fintan Walton , CEO, ...
Breaking Medicine Technology:Small Cap IR - Empowering the Age of Genetic Enlightenment 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5PharmaVentures Completes M&A Deal for Technology in the Stem Cell & Regenerative Medicine Sector 2
... 6 TargeGen, Inc. today announced that,the Company,s ... and the,Company plans to initiate a multi-center clinical ... highly selective JAK2 inhibitor in,January, 2008. Additionally, TargeGen ... will be made at the 2007 ASH Conference,(Atlanta, ...
... Inc. (Nasdaq: BCRX ) today provided an ... Forodesine HCl Data to be Presented at American ... Chair, Dermatology, The University of,Texas M.D. Anderson Cancer ... Phase I/II clinical study of oral forodesine HCl ...
Cached Medicine Technology:TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH 2BioCryst Provides Forodesine HCl Update 2BioCryst Provides Forodesine HCl Update 3BioCryst Provides Forodesine HCl Update 4BioCryst Provides Forodesine HCl Update 5